A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...
Jefferies London Healthcare Conference 2025 November 18, 2025 3:30 AM ESTCompany ParticipantsWilliam Lewis - President, CEO ...
The list of new medicines recommended for approval at the October meeting of the EMA's human medicines committee includes Brinsupri, the first treatment for serious chronic lung disease non-cystic ...
Hosted on MSN
Hyundai Venue N Line: Photo Gallery
The Hyundai Venue N Line is a sportier iteration of the Venue. Powered by a 1.0L, three-cylinder turbo-petrol motor (118bhp/172Nm), prices of the new Venue N Line will be revealed alongside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback